43 related articles for article (PubMed ID: 19542915)
1. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications.
Chen BJ; Mariño-Enríquez A; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Aug; 36(8):1119-28. PubMed ID: 22790852
[TBL] [Abstract][Full Text] [Related]
2. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor PU.1 and immune cell differentiation (Review).
Li G; Hao W; Hu W
Int J Mol Med; 2020 Dec; 46(6):1943-1950. PubMed ID: 33125129
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous arteritis with intimal fibrin ring and immature myeloid cell infiltrate: lymphocytic thrombophilic arteritis or histiocytoid polyarteritis nodosa?
Fujimoto M; Miyake T; Kaku Y; Hirata M; Kabashima K; Haga H
Virchows Arch; 2023 Jun; 482(6):1079-1083. PubMed ID: 36964280
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CD163 in cutaneous spindle cell lesions.
Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase is a marker of cutaneous Langerhans' cell histiocytosis ("X")-a comparative study with S100 protein.
Kanitakis J; Fantini F; Pincelli C; Hermier C; Schmitt D; Thivolet J
Anticancer Res; 1991; 11(2):635-9. PubMed ID: 1648331
[TBL] [Abstract][Full Text] [Related]
7. Proliferation of HSP47-positive skin fibroblasts in dermatofibroma.
Kuroda K; Tajima S
J Cutan Pathol; 2008 Jan; 35(1):21-6. PubMed ID: 18095990
[TBL] [Abstract][Full Text] [Related]
8. Procollagen 1 - a marker of fibroblastic and fibrohistiocytic skin tumors.
Krustrup D; Rossen K; Thomsen HK
J Cutan Pathol; 2006 Sep; 33(9):614-8. PubMed ID: 16965335
[TBL] [Abstract][Full Text] [Related]
9. "Histiocytic markers" in melanoma.
Pernick NL; DaSilva M; Gangi MD; Crissman J; Adsay V
Mod Pathol; 1999 Nov; 12(11):1072-7. PubMed ID: 10574605
[TBL] [Abstract][Full Text] [Related]
10. The utility of PU.1 as an immunohistochemical marker for histiocytic and dendritic lesions of the skin.
Muirhead D; Stone MS; Syrbu SI
Am J Dermatopathol; 2009 Jul; 31(5):432-5. PubMed ID: 19542915
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous histiocytic proliferations.
van der Valk P; Meijer CJ
Dermatol Clin; 1985 Oct; 3(4):705-17. PubMed ID: 3916176
[TBL] [Abstract][Full Text] [Related]
12. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
Tardío JC
J Cutan Pathol; 2008 Dec; 35(12):1079-92. PubMed ID: 18976402
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
